Lista de obras - María E Sarasquete - Dominio Público Uruguay

A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients

artículo científico publicado en 2019

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

artículo científico publicado en 2016

A safety profile of medications used to treat Waldenström's macroglobulinemia.

artículo científico publicado en 2018

Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

artículo científico publicado en 2014

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

artículo científico publicado en 2016

Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.

artículo científico publicado en 2006

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).

artículo científico publicado en 2009

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

artículo científico publicado en 2009

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

scientific article published on 01 October 2008

Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.

artículo científico publicado en 2013

Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.

artículo científico publicado en 2018

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

artículo científico publicado en 2020

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

artículo científico publicado en 2013

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

artículo científico publicado en 2017

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

artículo científico publicado en 2010

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.

artículo científico publicado en 2016

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

artículo científico publicado en 2014

Different tools for the diagnosis and molecular follow-up of leukemias and lymphomas

artículo científico publicado en 2017

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

artículo científico publicado en 2013

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.

artículo científico publicado en 2008

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

artículo científico publicado en 2019

Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).

artículo científico publicado en 2011

From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation

artículo científico publicado en 2017

Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemia.

artículo científico publicado en 2006

Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder

artículo científico publicado en 2019

Genomic analysis of high-risk smoldering multiple myeloma.

artículo científico publicado en 2012

Genomic characterization of liver metastases from colorectal cancer patients.

artículo científico publicado en 2016

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

artículo científico publicado en 2017

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

artículo científico publicado en 2013

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

artículo científico publicado en 2009

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

artículo científico publicado en 2015

Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

artículo científico publicado en 2015

Identification of miRSNPs associated with the risk of multiple myeloma.

artículo científico publicado en 2016

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

scientific article published on 17 June 2019

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

artículo científico publicado en 2006

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

artículo científico publicado en 2012

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma

artículo científico publicado en 2015

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

artículo científico publicado en 2012

Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays

artículo científico publicado en 2010

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

artículo científico publicado en 2009

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

artículo científico publicado en 2016

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

artículo científico publicado en 2015

Microarray-Based Analysis of Spinal versus Intracranial Meningiomas: Different Clinical, Biological, and Genetic Characteristics Associated with Distinct Patterns of Gene Expression

article

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.

artículo científico publicado en 2016

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

artículo científico publicado en 2005

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

artículo científico publicado en 2005

Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

artículo científico publicado en 2012

Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia

scientific article published on 01 November 2007

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

artículo científico publicado en 2012

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

artículo científico publicado en 2020

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

artículo científico publicado en 2009

Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.

artículo científico publicado en 2014

Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

artículo científico publicado en 2014

Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines

artículo científico publicado en 2014

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

artículo científico publicado en 2015

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

artículo científico publicado en 2016

Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.

artículo científico publicado en 2017

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

artículo científico publicado en 2012

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma

artículo científico publicado en 2017

Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

artículo científico publicado en 2019

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

artículo científico publicado en 2012

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

artículo científico publicado en 2018

Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation

scientific article published on 29 June 2012

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status

artículo científico publicado en 2012

Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach

scientific article published on 28 September 2018

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

artículo científico publicado en 2010

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma

scientific article published on 17 October 2006

The cellular origin and malignant transformation of Waldenström macroglobulinemia.

artículo científico publicado en 2015

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

artículo científico publicado en 2015

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

scientific article published on 07 April 2008

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

artículo científico publicado en 2008

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

artículo científico publicado en 2012

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

artículo científico publicado en 2014

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.

artículo científico publicado en 2018

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

artículo científico publicado en 2010

Lista de obras de María E Sarasquete

A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

A safety profile of medications used to treat Waldenström's macroglobulinemia.

Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.

Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

Different tools for the diagnosis and molecular follow-up of leukemias and lymphomas

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).

From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation

Functional class switch recombination may occur 'in vivo' in Waldenström macroglobulinaemia.

Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder

Genomic analysis of high-risk smoldering multiple myeloma.

Genomic characterization of liver metastases from colorectal cancer patients.

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

Identification of miRSNPs associated with the risk of multiple myeloma.

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

Microarray-Based Analysis of Spinal versus Intracranial Meningiomas: Different Clinical, Biological, and Genetic Characteristics Associated with Distinct Patterns of Gene Expression

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

Molecular characterization of complete and incomplete immunoglobulin heavy chain gene rearrangements in hairy cell leukemia

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.

Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma

Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation

SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status

Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma

The cellular origin and malignant transformation of Waldenström macroglobulinemia.

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients